Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality

Ajay K. Parsaik, Rickey E. Carter, Lucas A. Myers, Ananda Basu, Yogish C Kudva

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: To report population burden of hypoglycemia requiring ambulance services and long term outcomes thereafter, among people with type 2 diabetes (T2D).Methods: We retrieved all ambulance calls made by T2D for hypoglycemia in Olmsted County, Minnesota, between January 1, 2003, and December 31, 2009. Results: Seven hundred eighteen calls were made by 503 T2D (age 69 ± 12 years, 51% male), of which 328 (65%) were on insulin (INS), 54 (11%) on insulin + noninsulin agents (NIAI), 95 (19%) on sulphonylurea alone or in combination with other noninsulin agents (SFU), 21 (4%) on nonsulphonylurea noninsulin agents (NSFU), and 5 (1%) on no therapy (excluded from further analysis). NSFU had lower repeated calls (INS 25%, NIAI 26%, SFU 12%, NSFU 5%; P = .02), emergency room transportation (ERT) (INS 62%, NIAI 67%, SFU 68%, NSFU 38%; P = .06), and hospitalizations (INS 31%, NIAI 46%, SFU 38%, NSFU 19%; P = .02) compared to other groups. In multivariable mortality model, increased age (P<.001) was associated with an increased risk of death, whereas hypoglycemia predisposing comorbidities (chronic liver disease, end stage renal disease, adrenal insufficiency) (P = .06) were associated with a borderline increased risk, but no association was found with treatment group, repeated calls, ERT, hospitalization and baseline diabetic end organ complications. Conclusion: To our knowledge, we report the first estimate of hypoglycemia requiring ambulance services among T2D, in contemporary clinical practice. NSFU cohort was associated with lower repeated calls, ERT, and hospitalizations compared to other therapeutic programs. Predictors of mortality post-hypoglycemia were age and hypoglycemia predisposing comorbidities.

Original languageEnglish (US)
Pages (from-to)29-35
Number of pages7
JournalEndocrine Practice
Volume19
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Ambulances
Hypoglycemia
Type 2 Diabetes Mellitus
Insulin
Mortality
Hospital Emergency Service
Hospitalization
Comorbidity
Adrenal Insufficiency
Chronic Kidney Failure
Liver Diseases
Chronic Disease
Therapeutics
Population

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality. / Parsaik, Ajay K.; Carter, Rickey E.; Myers, Lucas A.; Basu, Ananda; Kudva, Yogish C.

In: Endocrine Practice, Vol. 19, No. 1, 01.2013, p. 29-35.

Research output: Contribution to journalArticle

@article{0003bcbb743049919b971e815a21e5ed,
title = "Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality",
abstract = "Objective: To report population burden of hypoglycemia requiring ambulance services and long term outcomes thereafter, among people with type 2 diabetes (T2D).Methods: We retrieved all ambulance calls made by T2D for hypoglycemia in Olmsted County, Minnesota, between January 1, 2003, and December 31, 2009. Results: Seven hundred eighteen calls were made by 503 T2D (age 69 ± 12 years, 51{\%} male), of which 328 (65{\%}) were on insulin (INS), 54 (11{\%}) on insulin + noninsulin agents (NIAI), 95 (19{\%}) on sulphonylurea alone or in combination with other noninsulin agents (SFU), 21 (4{\%}) on nonsulphonylurea noninsulin agents (NSFU), and 5 (1{\%}) on no therapy (excluded from further analysis). NSFU had lower repeated calls (INS 25{\%}, NIAI 26{\%}, SFU 12{\%}, NSFU 5{\%}; P = .02), emergency room transportation (ERT) (INS 62{\%}, NIAI 67{\%}, SFU 68{\%}, NSFU 38{\%}; P = .06), and hospitalizations (INS 31{\%}, NIAI 46{\%}, SFU 38{\%}, NSFU 19{\%}; P = .02) compared to other groups. In multivariable mortality model, increased age (P<.001) was associated with an increased risk of death, whereas hypoglycemia predisposing comorbidities (chronic liver disease, end stage renal disease, adrenal insufficiency) (P = .06) were associated with a borderline increased risk, but no association was found with treatment group, repeated calls, ERT, hospitalization and baseline diabetic end organ complications. Conclusion: To our knowledge, we report the first estimate of hypoglycemia requiring ambulance services among T2D, in contemporary clinical practice. NSFU cohort was associated with lower repeated calls, ERT, and hospitalizations compared to other therapeutic programs. Predictors of mortality post-hypoglycemia were age and hypoglycemia predisposing comorbidities.",
author = "Parsaik, {Ajay K.} and Carter, {Rickey E.} and Myers, {Lucas A.} and Ananda Basu and Kudva, {Yogish C}",
year = "2013",
month = "1",
doi = "10.4158/EP12197.OR",
language = "English (US)",
volume = "19",
pages = "29--35",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "1",

}

TY - JOUR

T1 - Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality

AU - Parsaik, Ajay K.

AU - Carter, Rickey E.

AU - Myers, Lucas A.

AU - Basu, Ananda

AU - Kudva, Yogish C

PY - 2013/1

Y1 - 2013/1

N2 - Objective: To report population burden of hypoglycemia requiring ambulance services and long term outcomes thereafter, among people with type 2 diabetes (T2D).Methods: We retrieved all ambulance calls made by T2D for hypoglycemia in Olmsted County, Minnesota, between January 1, 2003, and December 31, 2009. Results: Seven hundred eighteen calls were made by 503 T2D (age 69 ± 12 years, 51% male), of which 328 (65%) were on insulin (INS), 54 (11%) on insulin + noninsulin agents (NIAI), 95 (19%) on sulphonylurea alone or in combination with other noninsulin agents (SFU), 21 (4%) on nonsulphonylurea noninsulin agents (NSFU), and 5 (1%) on no therapy (excluded from further analysis). NSFU had lower repeated calls (INS 25%, NIAI 26%, SFU 12%, NSFU 5%; P = .02), emergency room transportation (ERT) (INS 62%, NIAI 67%, SFU 68%, NSFU 38%; P = .06), and hospitalizations (INS 31%, NIAI 46%, SFU 38%, NSFU 19%; P = .02) compared to other groups. In multivariable mortality model, increased age (P<.001) was associated with an increased risk of death, whereas hypoglycemia predisposing comorbidities (chronic liver disease, end stage renal disease, adrenal insufficiency) (P = .06) were associated with a borderline increased risk, but no association was found with treatment group, repeated calls, ERT, hospitalization and baseline diabetic end organ complications. Conclusion: To our knowledge, we report the first estimate of hypoglycemia requiring ambulance services among T2D, in contemporary clinical practice. NSFU cohort was associated with lower repeated calls, ERT, and hospitalizations compared to other therapeutic programs. Predictors of mortality post-hypoglycemia were age and hypoglycemia predisposing comorbidities.

AB - Objective: To report population burden of hypoglycemia requiring ambulance services and long term outcomes thereafter, among people with type 2 diabetes (T2D).Methods: We retrieved all ambulance calls made by T2D for hypoglycemia in Olmsted County, Minnesota, between January 1, 2003, and December 31, 2009. Results: Seven hundred eighteen calls were made by 503 T2D (age 69 ± 12 years, 51% male), of which 328 (65%) were on insulin (INS), 54 (11%) on insulin + noninsulin agents (NIAI), 95 (19%) on sulphonylurea alone or in combination with other noninsulin agents (SFU), 21 (4%) on nonsulphonylurea noninsulin agents (NSFU), and 5 (1%) on no therapy (excluded from further analysis). NSFU had lower repeated calls (INS 25%, NIAI 26%, SFU 12%, NSFU 5%; P = .02), emergency room transportation (ERT) (INS 62%, NIAI 67%, SFU 68%, NSFU 38%; P = .06), and hospitalizations (INS 31%, NIAI 46%, SFU 38%, NSFU 19%; P = .02) compared to other groups. In multivariable mortality model, increased age (P<.001) was associated with an increased risk of death, whereas hypoglycemia predisposing comorbidities (chronic liver disease, end stage renal disease, adrenal insufficiency) (P = .06) were associated with a borderline increased risk, but no association was found with treatment group, repeated calls, ERT, hospitalization and baseline diabetic end organ complications. Conclusion: To our knowledge, we report the first estimate of hypoglycemia requiring ambulance services among T2D, in contemporary clinical practice. NSFU cohort was associated with lower repeated calls, ERT, and hospitalizations compared to other therapeutic programs. Predictors of mortality post-hypoglycemia were age and hypoglycemia predisposing comorbidities.

UR - http://www.scopus.com/inward/record.url?scp=84881540183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881540183&partnerID=8YFLogxK

U2 - 10.4158/EP12197.OR

DO - 10.4158/EP12197.OR

M3 - Article

C2 - 23186970

AN - SCOPUS:84881540183

VL - 19

SP - 29

EP - 35

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 1

ER -